|
🐜
|
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
19 auth.
David L. Thomas,
C. Thio,
Maureen P. Martin,
Y. Qi,
D. Ge,
C. O’hUigin,
J. Kidd,
K. Kidd,
S. Khakoo,
G. Alexander,
...
J. Goedert,
G. Kirk,
S. Donfield,
H. Rosen,
L. Tobler,
M. Busch,
J. Mchutchison,
D. Goldstein,
M. Carrington
|
11 |
2009 |
11
🐜
|
|
🦁
|
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
18 auth.
S. Khakoo,
C. Thio,
Maureen P. Martin,
C. Brooks,
Xiaojiang Gao,
J. Astemborski,
Jie Cheng,
J. Goedert,
D. Vlahov,
M. Hilgartner,
...
S. Cox,
A. Little,
G. Alexander,
M. Cramp,
S. O’Brien,
W. Rosenberg,
David L. Thomas,
M. Carrington
|
10 |
2004 |
10
🦁
|
|
🐜
|
MAIT cells are activated during human viral infections
55 auth.
B. van Wilgenburg,
Iris Scherwitzl,
E. Hutchinson,
T. Leng,
A. Kurioka,
Corinna A. Kulicke,
C. D. de Lara,
S. Cole,
Sirijitt Vasanawathana,
W. Limpitikul,
P. Malasit,
D. Young,
Laura Denney,
E. Barnes,
J. Ball,
...
Gary Burgess,
G. Cooke,
J. Dillon,
C. Gore,
G. Foster,
Neil Guha,
R. Halford,
C. Herath,
C. Holmes,
A. Howe,
E. Hudson,
W. Irving,
S. Khakoo,
D. Koletzki,
N. Martin,
T. Mbisa,
J. McKeating,
J. McLauchlan,
A. Miners,
A. Murray,
P. Shaw,
P. Simmonds,
C. Spencer,
P. Targett-Adams,
E. Thomson,
P. Vickerman,
N. Zitzmann,
M. D. Moore,
P. Fabris,
M. Giordani,
Y. Oo,
S. Laidlaw,
L. Dustin,
L. Ho,
F. Thompson,
N. Ramamurthy,
J. Mongkolsapaya,
C. Willberg,
G. Screaton,
P. Klenerman
|
8 |
2016 |
8
🐜
|
|
🐜
|
HIV-1 adaptation to NK cell mediated immune pressure
13 auth.
G. Alter,
D. Heckerman,
A. Schneidewind,
L. Fadda,
C. Kadie,
J. Carlson,
C. Oniangue-Ndza,
Maureen P. Martin,
Bin Li,
S. Khakoo,
...
M. Carrington,
Todd M. Allen,
M. Altfeld
|
8 |
2011 |
8
🐜
|
|
🦁
|
KIR and disease: a model system or system of models?
S. Khakoo,
M. Carrington
|
8 |
2006 |
8
🦁
|
|
🐜
|
Genome-Wide Association Study of Spontaneous Resolution of Hepatitis C Virus Infection: Data From Multiple Cohorts
27 auth.
P. Duggal,
C. Thio,
G. Wojcik,
J. Goedert,
A. Mangia,
R. Latanich,
A. Kim,
G. Lauer,
R. Chung,
M. Peters,
G. Kirk,
S. Mehta,
A. Cox,
S. Khakoo,
L. Alric,
...
M. Cramp,
S. Donfield,
B. Edlin,
L. Tobler,
M. Busch,
G. Alexander,
H. Rosen,
Xiaojiang Gao,
M. Abdel-hamid,
R. Apps,
M. Carrington,
David L. Thomas
|
7 |
2013 |
7
🐜
|
|
🐢
|
Activation of natural killer cells during acute infection with hepatitis C virus.
9 auth.
B. Amadei,
S. Urbani,
Angelica M. Cazaly,
P. Fisicaro,
A. Zerbini,
Parvin S. Ahmed,
...
G. Missale,
C. Ferrari,
S. Khakoo
|
7 |
2010 |
7
🐢
|
|
🐢
|
Peptide antagonism as a mechanism for NK cell activation
14 auth.
L. Fadda,
Gwenoline Borhis,
Parvin S. Ahmed,
K. Cheent,
Sophie V. Pageon,
Angelica M. Cazaly,
S. Stathopoulos,
D. Middleton,
A. Mulder,
F. Claas,
...
T. Elliott,
D. Davis,
M. Purbhoo,
S. Khakoo
|
7 |
2010 |
7
🐢
|
|
🐢
|
Consistent beneficial effects of killer cell immunoglobulin‐like receptor 2DL3 and group 1 human leukocyte antigen‐C following exposure to hepatitis C virus
11 auth.
S. Knapp,
U. Warshow,
D. Hegazy,
L. Brackenbury,
I. Guha,
A. Fowell,
...
A. Little,
G. Alexander,
W. Rosenberg,
M. Cramp,
S. Khakoo
|
7 |
2010 |
7
🐢
|
|
🦁
|
Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions.
12 auth.
S. Khakoo,
P. Glue,
L. Grellier,
Beverley Wells,
Allan Bell,
Clive Dash,
...
I. Murray-Lyon,
David Lypnyj,
David Lypnyj,
B. Flannery,
Karen Walters,
G. Dusheiko
|
7 |
1998 |
7
🦁
|
|
🐢
|
Immunotherapy for hepatocellular carcinoma: Current and future
Michael P. Johnston,
S. Khakoo
|
7 |
2019 |
7
🐢
|
|
🐜
|
The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation.
7 auth.
M. Luevano,
Mehri Daryouzeh,
R. Alnabhan,
S. Querol,
S. Khakoo,
A. Madrigal,
...
A. Saudemont
|
7 |
2012 |
7
🐜
|
